Hologic (Germany) Performance
| HO1 Stock | EUR 69.00 0.50 0.73% |
The company retains a Market Volatility (i.e., Beta) of 0.15, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Hologic's returns are expected to increase less than the market. However, during the bear market, the loss of holding Hologic is expected to be smaller as well. At this point, Hologic has a negative expected return of -0.0623%. Please make sure to check out Hologic's total risk alpha, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to decide if Hologic performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Hologic has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Hologic is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 1.2 B | |
| Total Cashflows From Investing Activities | -206.3 M |
Hologic |
Hologic Relative Risk vs. Return Landscape
If you would invest 7,200 in Hologic on September 28, 2024 and sell it today you would lose (300.00) from holding Hologic or give up 4.17% of portfolio value over 90 days. Hologic is currently producing negative expected returns and takes up 1.1295% volatility of returns over 90 trading days. Put another way, 10% of traded stocks are less volatile than Hologic, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Hologic Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hologic's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Hologic, and traders can use it to determine the average amount a Hologic's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0552
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HO1 |
Estimated Market Risk
| 1.13 actual daily | 10 90% of assets are more volatile |
Expected Return
| -0.06 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Hologic is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hologic by adding Hologic to a well-diversified portfolio.
Hologic Fundamentals Growth
Hologic Stock prices reflect investors' perceptions of the future prospects and financial health of Hologic, and Hologic fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Hologic Stock performance.
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0858 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.29 % | |||
| Current Valuation | 18.25 B | |||
| Shares Outstanding | 246.55 M | |||
| Price To Book | 3.70 X | |||
| Price To Sales | 3.52 X | |||
| Revenue | 4.86 B | |||
| EBITDA | 2.11 B | |||
| Cash And Equivalents | 601.8 M | |||
| Cash Per Share | 2.24 X | |||
| Total Debt | 2.81 B | |||
| Debt To Equity | 134.00 % | |||
| Book Value Per Share | 20.66 X | |||
| Cash Flow From Operations | 2.13 B | |||
| Earnings Per Share | 3.64 X | |||
| Total Asset | 9.07 B | |||
About Hologic Performance
By analyzing Hologic's fundamental ratios, stakeholders can gain valuable insights into Hologic's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Hologic has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Hologic has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Hologic, Inc., a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company was founded in 1985 and is headquartered in Marlborough, Massachusetts. HOLOGIC INC is traded on Frankfurt Stock Exchange in Germany.Things to note about Hologic performance evaluation
Checking the ongoing alerts about Hologic for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Hologic help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Hologic generated a negative expected return over the last 90 days | |
| Hologic has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Over 100.0% of the company shares are owned by institutional investors |
- Analyzing Hologic's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Hologic's stock is overvalued or undervalued compared to its peers.
- Examining Hologic's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Hologic's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Hologic's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Hologic's stock. These opinions can provide insight into Hologic's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Hologic Stock analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |